12 Health Care Stocks Moving In Friday's After-Market Session

Universe Pharmaceuticals INC
Tvardi Therapeutics Inc.
Healthcare Triangle, Inc.
Disc Medicine, Inc.
Picard Medical, Inc.

Universe Pharmaceuticals INC

UPC

0.00

Tvardi Therapeutics Inc.

TVRD

0.00

Healthcare Triangle, Inc.

HCTI

0.00

Disc Medicine, Inc.

IRON

0.00

Picard Medical, Inc.

PMI

0.00

Gainers

  • Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 168.2% to $7.94 during Friday's after-market session. The market value of their outstanding shares is at $1.8 million.
  • Tvardi Therapeutics (NASDAQ:TVRD) shares moved upwards by 28.63% to $1.93. The company's market cap stands at $22.1 million.
  • Healthcare Triangle (NASDAQ:HCTI) shares rose 19.11% to $2.43. The company's market cap stands at $3.8 million.
  • Disc Medicine (NASDAQ:IRON) stock increased by 13.66% to $85.0. The market value of their outstanding shares is at $2.6 billion.
  • Picard Medical (AMEX:PMI) shares moved upwards by 10.09% to $0.16. The company's market cap stands at $14.9 million.
  • Citius Oncology (NASDAQ:CTOR) shares rose 9.25% to $0.68. The company's market cap stands at $61.3 million.

Losers

  • Jupiter Neurosciences (NASDAQ:JUNS) stock fell 29.1% to $0.2 during Friday's after-market session. The market value of their outstanding shares is at $11.4 million.
  • Akari Therapeutics (NASDAQ:AKTX) shares decreased by 13.15% to $9.32. The market value of their outstanding shares is at $14.9 million.
  • Solana (NASDAQ:HSDT) stock declined by 10.92% to $1.54. The market value of their outstanding shares is at $86.9 million.
  • CalciMedica (NASDAQ:CALC) shares decreased by 9.3% to $0.74. The company's market cap stands at $9.8 million.
  • Can Fite Biopharma (AMEX:CANF) shares declined by 8.37% to $2.52. The market value of their outstanding shares is at $6.2 million.
  • Zentek (NASDAQ:ZTEK) shares decreased by 7.62% to $0.45. The company's market cap stands at $41.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.